SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-612675
Filing Date
2016-06-03
Accepted
2016-06-03 16:27:41
Documents
15
Period of Report
2016-07-14
Effectiveness Date
2016-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d175958ddef14a.htm DEF 14A 806006
2 GRAPHIC g175958dotdot.jpg GRAPHIC 349
3 GRAPHIC g175958stp003.jpg GRAPHIC 114395
4 GRAPHIC g175958stp004.jpg GRAPHIC 121803
5 GRAPHIC g175958stp005.jpg GRAPHIC 153789
6 GRAPHIC g175958stp006a.jpg GRAPHIC 9962
7 GRAPHIC g175958stp006b.jpg GRAPHIC 7972
8 GRAPHIC g175958stp085.jpg GRAPHIC 57316
9 GRAPHIC g175958stp086.jpg GRAPHIC 236841
10 GRAPHIC g175958stp087.jpg GRAPHIC 140323
11 GRAPHIC g175958stp088.jpg GRAPHIC 119172
12 GRAPHIC g175958stp089.jpg GRAPHIC 137757
13 GRAPHIC g175958txpg004a.jpg GRAPHIC 1716
14 GRAPHIC g175958txpg004b.jpg GRAPHIC 1043
15 GRAPHIC g175958txpg004c.jpg GRAPHIC 1266
  Complete submission text file 0001193125-16-612675.txt   2326349
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 161696022
SIC: 2834 Pharmaceutical Preparations